This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Regeneron Pharmaceuticals Inc. (REGN) inched 0.73% higher to $631.20 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.72% to 4,682.85 and the Dow Jones Industrial Average rising 0.50% to 36,100.31. This was the stock's third consecutive day of gains. Regeneron Pharmaceuticals Inc. closed $55.42 below its 52-week high ($686.62), which the company reached on September 3rd.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson (JNJ) rose 1.20% to $165.01, Novartis AG ADR (NOVN.EB) fell 0.42% to $82.49, and Amgen Inc. (AMGN) fell 0.08% to $211.39. Trading volume (512,493) remained 264,870 below its 50-day average volume of 777,363.
Data source: Dow Jones Market Data, FactSet. Data compiled November 12, 2021.
(END) Dow Jones Newswires
November 12, 2021 17:19 ET (22:19 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.